Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Oria Meds vs Renlo Health

By GLP-1 ScorecardUpdated

Oria Meds
Site position #283

Lower grade

Renlo Health
Site position #41

Higher grade

Score comparison

Renlo Health has the higher recorded score — 79.7/100 to 63.6/100.

Renlo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRenlo Health +30
54
84
Dose & formulationRenlo Health +8
64
72
Clinical oversightRenlo Health +23
65
88
Labs & monitoringRenlo Health +6
52
58
FulfillmentOria Meds +3
93
90
Contract termsRenlo Health +23
67
90
Oria Meds · top barRenlo Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricOria MedsRenlo Health
WeighScore63.6/10079.7/100
GradeCC+
Site position#283#41
Semaglutide$199/mo (first month $89; the three- and six-month plans both cost $209 a month)$199/mo, billed monthly at every dose
Tirzepatide$369/mo (first month $129; three months $316/mo, six months $299/mo)$269/mo, billed monthly at every dose
CoverageAll 50 statesNot publicly listed
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Oria Meds

Site position #283 · C

Strengths

  • Names its dispensing pharmacy, PerfectRx, with a street address and a phone number
  • Free shipping and interest-free installments are offered at checkout
  • The intake's plan menu returned identical ladders in two different states, so the price is not being varied by geography in the states tested
  • Coverage is stated as all 50 states, subject to provider availability

What to consider

  • Neither semaglutide nor tirzepatide is named anywhere on the public site; the molecule first appears at step two of the intake, after name, email, phone and shipping address are collected
  • The homepage sells “starting at $149” and “starting at $249” and neither figure appears in the intake in either state tested
  • The semaglutide ladder is inverted: one month is $199 a month, three months and six months are both $209 a month
  • $89 and $129 are first-month promotional rates; the standing rates are $199 and $369
  • A second price table sits in the homepage script and renders nowhere, quoting a $329 tirzepatide figure the live intake contradicts
  • Two different scarcity counters appear on consecutive checkout screens, and review turnaround is stated as 24 hours in one place and 48 in another
  • No legal entity, state of organization or governing law is published, and no clinician or NPI is named
Renlo Health

Site position #41 · C+

Strengths

  • The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
  • A genuine all-in line: medication, injection supplies, provider evaluation, ongoing care, expedited shipping and unlimited care-team messaging, with no membership or consultation fees
  • Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
  • Same price at every dose with a price-lock badge
  • A four-month money-back guarantee, and cancel anytime with no fee

What to consider

  • A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
  • That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
  • A comparison table headed "Most GLP-1 providers" quotes $270, $365 and $445 by dose while naming no provider and citing no source
  • A site-wide $50 code means the advertised figure is not the first amount charged
  • No lab protocol is published, and there is no oral or brand route

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard